Calcifediol [kalcifediol]
- Terms
 - 
            
25-hydroxyvitamin D3
hydroxycholekalciferol
kalcidiol
Uperold 
- 
            
25-Hydroxycholecalciferol
25-Hydroxycholecalciferol Monohydrate
25-Hydroxyvitamin D 3
25-Hydroxyvitamin D3
Calcidiol
Calcifediol Anhydrous
Calcifediol, (3 alpha,5Z,7E)-Isomer
Calcifediol, (3 beta,5E,7E)-Isomer
Calderol
Dedrogyl
Hidroferol 
The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.
- Annotation
 - deficiency: coordinate CALCIFEDIOL /defic (IM) with VITAMIN D DEFICIENCY (IM)
 - nedostatek: kombinuj deskriptory KALCIFEDIOL s podheslem /nedostatek (IM) a NEDOSTATEK VITAMINU D (IM)
 
- DUI
 - D002112 MeSH Browser
 - CUI
 - M0003141
 - CAS
 - 9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3beta,5Z,7E)-
 - Previous indexing
 - Cholecalciferols (1966-1972); Hydroxycholecalciferols (1972-1982)
 - History note
 - 83
 - Public note
 - 83
 
Allowable subheadings
- AD
 - administration & dosage 5
 - AE
 - adverse effects
 - AG
 - agonists
 - AA
 - analogs & derivatives
 - AN
 - analysis 5
 - AI
 - antagonists & inhibitors
 - BI
 - biosynthesis
 - BL
 - blood 37
 - CF
 - cerebrospinal fluid
 - CS
 - chemical synthesis
 - CH
 - chemistry
 - CL
 - classification
 - DF
 - deficiency 4
 - EC
 - economics
 - GE
 - genetics 1
 - HI
 - history
 - IM
 - immunology
 - IP
 - isolation & purification 1
 - ME
 - metabolism 7
 - PK
 - pharmacokinetics
 - PD
 - pharmacology 3
 - PH
 - physiology 2
 - PO
 - poisoning
 - RE
 - radiation effects 1
 - ST
 - standards 4
 - SD
 - supply & distribution
 - TU
 - therapeutic use 2
 - TO
 - toxicity
 - UR
 - urine